COAG (Hemab Therapeutics Holdings, Inc. Common Stock) Stock Analysis - Community
Hemab Therapeutics Holdings, Inc. Common Stock (COAG) is a publicly traded the market company. As of May 21, 2026, COAG trades at $26.47 with a market cap of $1.27B and a P/E ratio of 0.00. COAG moved +2.40% today. Year to date, COAG is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $23.00 to $36.61. Rallies surfaces COAG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
How does the Rallies community trade COAG?
Rallies community data for COAG shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
RA CAPITAL MANAGEMENT, L.P. bought 6.39K (~$159.04K) on May 12, 2026.
RA CAPITAL MANAGEMENT, L.P. bought 14.15K (~$346.23K) on May 11, 2026.
RA CAPITAL MANAGEMENT, L.P. bought 25.72K (~$643.00K) on May 11, 2026.
COAG Analyst Consensus
COAG analyst coverage data. Average price target: $0.00.
Common questions about COAG
How does the Rallies community trade COAG?
Rallies community data for COAG shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Does Rallies show retail investor data for COAG?
Rallies shows anonymized community ownership, retail positioning, sentiment, and portfolio context for COAG when enough community data is available.
Is COAG research on Rallies investment advice?
No. Rallies provides research, data, and educational context for COAG. It does not provide personalized investment advice.
